American Heart Journal
Volume 158, Issue 5 , Pages 792-798 , November 2009

Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: Results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) Trial

  • Sana M. Al-Khatib, MD, MHS

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • Division of Cardiology, Duke University Medical Center, Durham, NC
    • Corresponding Author InformationReprint requests: Sana M. Al-Khatib, MD, MHS, Duke Clinical Research Institute, P.O. Box 17969, Durham, NC 27710.
    • ,
  • Gail Hafley, MS

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • Robert A. Harrington, MD

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • Division of Cardiology, Duke University Medical Center, Durham, NC
    • ,
  • Michael J. Mack, MD

      Affiliations

    • Cardiopulmonary Research Science and Technology Institute, Dallas, TX
    • ,
  • Thomas Bruce Ferguson, MD

      Affiliations

    • East Carolina University, Greenville, NC
    • ,
  • Eric D. Peterson, MD, MPH

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • Division of Cardiology, Duke University Medical Center, Durham, NC
    • ,
  • Robert M. Califf, MD

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • Division of Cardiology, Duke University Medical Center, Durham, NC
    • ,
  • Nicholas T. Kouchoukos, MD

      Affiliations

    • Missouri Baptist Medical Center, St. Louis, MO
    • ,
  • John H. Alexander, MD, MHS

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • Division of Cardiology, Duke University Medical Center, Durham, NC

Received 30 January 2009 ,Accepted 3 September 2009.

References 

  1. Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. JAMA. 1996;276:300–306
  2. Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;291:1720–1729
  3. Villareal RP, Hariharan R, Liu BC, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004;43:742–748
  4. Amar D, Shi W, Hogue CW, et al. Clinical prediction rule for atrial fibrillation after coronary artery bypass grafting. J Am Coll Cardiol. 2004;44:1248–1253
  5. Mariscalco G, Lorusso R, Kleersy C, et al. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg. 2007;84:1158–1164
  6. Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation. 1996;94:390–397
  7. Creswell LL, Schuessler RB, Rosenbloom M, et al. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 1993;56:539–549
  8. Auer J, Weber T, Berent R, et al. Postoperative atrial fibrillation independently predicts prolongation of hospital stay after cardiac surgery. J Cardiovasc Surg. 2005;46:583–588
  9. Almassi GH, Schowalter T, Nicolosi AC, et al. Atrial fibrillation after cardiac surgery: a major morbid event?. Ann Surg. 1997;226:501–511
  10. Stamou SC, Sangas G, Hill PC, et al. Atrial fibrillation after beating heart surgery. Am J Cardiol. 2000;86:64–67
  11. Ali IM, Sanalla AA, Clark V. Beta-blocker effects on postoperative atrial fibrillation. Eur J Cardiothorac Surg. 1997;11:1154–1157
  12. Connolly SJ, Cybulsky I, Lamy A, et al. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study. Am Heart J. 2003;145:226–232
  13. Khuri SF, Okike ON, Josa M, et al. Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting. Am J Cardiol. 1987;60:51D–58D
  14. Silverman NA, Wright R, Levitsky S. Efficacy of low-dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Ann Surg. 1982;196:194–197
  15. Andrews TC, Reimold SC, Berlin JA, et al. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. Circulation. 1991;84:III236–III244
  16. Crystal E, Garfinkle MS, Connolly SS, et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2004;CD003611
  17. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006;48:854–906
  18. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol. 2004;44:e213–e310
  19. Daoud EG, Strickberger SA, Man KC, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med. 1997;337:1785–1791
  20. Guarnieri T, Nolan S, Gottlieb SO, et al. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial. J Am Coll Cardiol. 1999;34:343–347
  21. Mitchell LB, Exner DV, Wyse DG, et al. Prophylactic oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial. JAMA. 2005;294:3093–3100
  22. Zebis LR, Christensen TD, Kristiansen IS, et al. Amiodarone cost effectiveness in preventing atrial fibrillation after coronary artery bypass graft surgery. Ann Thorac Surg. 2008;85:28–32
  23. Budeus M, Hennersdorf M, Perings S, et al. Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study. Eur Heart J. 2006;27:1584–1591
  24. Gillespie EL, Coleman CI, Sander S, et al. Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis. Ann Pharmacotherapy. 2005;39:1409–1415
  25. White CM, Giri S, Tsikouris JP, et al. A comparison of two individual amiodarone regimens to placebo in open heart surgery patients. Ann Thorac Surg. 2002;74:69–74
  26. PREVENT-IV Investigators . Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: Prevent IV: A randomized controlled trial. JAMA. 2005;294:2446–2454
  27. Alexander JH, Ferguson TB, Joseph DM, et al. The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics. Am Heart J. 2005;150:643–649
  28. Member Institution Listings . Association of American Medical Colleges Web site. Available at: http://services.aamc.org/memberlistingsLast accessed August 25, 2009. (accessed on 7/13/2009)

 Results of this analysis were presented in an abstract form at the American College of Cardiology 54th Annual Scientific Sessions, Orlando, FL, March 2005.

PII: S0002-8703(09)00720-0

doi: 10.1016/j.ahj.2009.09.003

American Heart Journal
Volume 158, Issue 5 , Pages 792-798 , November 2009

Article Tools

* Image Usage & Resolution